Sera Prognostics, Inc. Class A Common Stock
SERA US81749D1072
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -42% | -84% | 356% | 36% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Harrison Robert Gardner CIO |
3.18 USD |
2,000 Sold |
6,360 USD |
07/10/2025 | 07/10/2025 |
| Mirza Mansoor Raza |
3.16 USD |
227 Sold |
717 USD |
06/10/2025 | 06/10/2025 |
| Lindgardt Zhenya CEO |
3.13 USD |
3,246 Sold |
10,160 USD |
11/09/2025 | 11/09/2025 |
| Harrison Robert Gardner CIO |
3.13 USD |
645 Sold |
2,019 USD |
11/09/2025 | 11/09/2025 |
| Kearney Paul SR OFF |
3.13 USD |
1,271 Sold |
3,978 USD |
11/09/2025 | 11/09/2025 |
| Jackson Benjamin SR OFF |
3.13 USD |
934 Sold |
2,923 USD |
11/09/2025 | 11/09/2025 |
| Boniface John J. CSO |
3.13 USD |
1,395 Sold |
4,366 USD |
11/09/2025 | 11/09/2025 |
| Aerts Austin CFO |
3.13 USD |
915 Sold |
2,864 USD |
11/09/2025 | 11/09/2025 |
| Lindgardt Zhenya CEO |
3.15 USD |
21,158 Sold |
66,648 USD |
09/09/2025 | 09/09/2025 |
| Lawrence Sandra Aj |
3.05 USD |
3,899 Sold |
11,892 USD |
09/09/2025 | 09/09/2025 |